EGFR and cancer: Basically, MicorRNAs in cancer, glioma, chronic myeloid leukemia, non-small cell lung cancer, EGFR tyrosine kinase inhibitör resistance, prostate cancer, ErbB signaling pathway, melanoma, endocrine resistance, and growth hormone synthesis the top 10 pathways that occur in diabetic complications are shown in Fig. 5.